Stock Locations

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

1993-63-15-Fluoro-2-methoxypyrimidin-4-amine

● In Stock

Catalogue No.:	VE0019532
CAS No.:	1993-63-1
Mol. Formula:	C5H6FN3O
Mol. Weight:	143.12 g/mol

Request a quote

Add to RFQ list

Additional information on CAS 1993-63-1

Parent drug

Capecitabine

IUPAC Name

5-fluoro-2-methoxypyrimidin-4-amine

Pharmacopoeial Synonyms

N/A

Other Synonyms

4-Amino-5-fluoro-2-methoxypyrimidine;2-Methoxy-5-fluoro-4-aminopyrimidine;4-Pyrimidinamine, 5-fluoro-2-methoxy- (9CI);5-Fluoro-2-methoxy-4-pyrimidinamine;5-Fluoro-2-methoxy-pyrimidin-4-ylamine

Smiles

COc1ncc(F)c(N)n1

InChI

InChI=1S/C5H6FN3O/c1-10-5-8-2-3(6)4(7)9-5/h2H,1H3,(H2,7,8,9)

Shipping Condition

Ambient Temperature

Characterization Data (Included)

HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, and Structure Elucidation Report (SER).

Additional Characterization Data

QNMR, D2O Exchange, 13C NMR, 13C APT, COSY NMR, NOESY NMR, 15N NMR, HSQC NMR, HMQC NMR, and HMBC NMR. These are available upon request and may be free or subject to additional charges.

Description

5-Fluoro-2-methoxypyrimidin-4-amine is a well-characterized reference material that meets stringent regulatory standards set by USP, EMA, JP, and BP. It plays a key role in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial production of Capecitabine. To ensure accuracy and reliability across various analytical applications, it includes a comprehensive Structure Elucidation Report (SER), providing valuable insights for quality control and method development.